Endo Acquires Par for $8.05 Billion
The Irish company Endo International announced that it would acquire Par Pharmaceutical for $8.05 billion.
Ireland-based company Endo International announced on May 18, 2015 that it would acquire Par Pharmaceutical in a transaction valued at $8.05 billion, which includes the assumption of Par debt. The acquisition gives Endo full access to Par Pharmaceutical, specializing in high-barrier-to-entry generic drugs; Par Specialty Pharmaceuticals, providing niche brands; and Par Sterile Products, developing and manufacturing branded and generic aseptic injectable pharmaceuticals. In 2015, Par acquired Ethics Bio, a contract research organization, and Innoteq a developer and manufacturer of coated products.
"We share Endo's goal of developing and commercializing generic drugs in areas of greatest revenue potential, complex formulations, and longer life cycles," said Paul Campanelli, CEO of Par Pharmaceutical, in a press release.
Par’s portfolio is host to almost 100 products including oral solids, oral suspensions, injectables, and high barrier-to-entry products. Par’s pipeline consists of more than 200 abbreviated new drug applications (ANDA), with expectations that it will generate 20–25 ANDA filings in 2015, 2016, and 2017, according to a press release. The transaction is expected to close in the second half of 2015.
Source: Endo
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
